TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|7-1048|1|91-99

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.7-1048, Iss.1, 2015-10, pp. : 91-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1

By  

Acta Haematologica, Vol. 129, Iss. 4, 2013-01 ,pp. : 243-250

Karger

Access to resources Recommend Favorite

Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 1, 2015-10 ,pp. : 137-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 137-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Micronuclei and Nuclear Abnormalities Observed in Erythroblasts in Myelodysplastic Syndromes and in de novo Acute Leukemia after Treatment

By  

Acta Haematologica, Vol. 101, Iss. 1, 1999-03 ,pp. : 32-40

Karger

Access to resources Recommend Favorite